Compare HIPO & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIPO | BVS |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 540 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 737.1M | 716.8M |
| IPO Year | N/A | 2016 |
| Metric | HIPO | BVS |
|---|---|---|
| Price | $25.61 | $8.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $38.67 | $14.00 |
| AVG Volume (30 Days) | 104.3K | ★ 660.7K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $28.28 | $7.52 |
| Revenue Next Year | $22.33 | $7.06 |
| P/E Ratio | ★ $7.64 | $226.25 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.08 | $5.81 |
| 52 Week High | $38.98 | $11.25 |
| Indicator | HIPO | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 42.14 |
| Support Level | $24.66 | $8.55 |
| Resistance Level | $26.93 | $9.24 |
| Average True Range (ATR) | 0.85 | 0.48 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 51.19 | 48.46 |
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.